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Dr Mitruka (Rancho Mirage, Calif). I think there is little question
that early revascularization confers a survival advantage in patients
with AMI. This has been demonstrated by the cardiologists perform-
ing PCI in this patient population. Indeed, the door to balloon time is
now a benchmark for programmatic success. This early intervention
has resulted, however, in many surgeons being cajoled or even co-
erced into performing high-risk operations earlier than may be ben-
eficial. The optimal timing of surgical revascularization after AMI
remains somewhat controversial, although it is generally accepted
that waiting is better. This was demonstrated by the Columbia group
evaluating New York State databases, and they showed that waiting
to operate, especially in patients with transmural infarcts, results in
better outcomes.
This retrospective study performed by the Johns Hopkins group
using California discharge data adds to the growing body of litera-
ture that attempts to objectify the optimal timing of CABG after
AMI. This group is to be congratulated for a statistical tour de force
that overcame many of the inherent limitations and biases of a retro-
spective study in drawing meaningful conclusions. By using multi-
ple logistic and linear regression, as well as propensity-adjusted
multivariate analysis, the risk of adverse events could be assessed
while controlling for factors associated with high preoperative clin-
ical acuity. With this methodology, they were able to conclude that
early CABG less than 3 days after an AMI was an independent pre-
dictor of mortality after controlling for clinical acuity and surgical
propensity. Identifying the optimal timing of CABG after AMI to
be 3 to 5 days to reduce postoperative mortality will be of clear clin-
ical benefit. Furthermore, outlining that patients with higher acuity
undergoing operation sooner will have higher morbidity will be
beneficial in aligning outcome expectations between surgeons and
our referring physicians. With that long-winded preamble, I have
a few questions that you are invited to answer individually.
It is generally well accepted by most surgeons that preoperative
assessment of left ventricular function, particularly after an AMI,
is one of the best predictors of postoperative outcome. Yet, leftacic and Cardiovascular Surgery c Volume 135, Number 3 509
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CDventricular function in this particular study as a variable was not
assessed. Could you comment as to why?
DrWeiss. I agree with you that left ventricular function is impor-
tant. The reason we were not able to include it was because it was
simply not a component of the California discharge database.
Clearly these administrative databases have limitations, the princi-
ple one being a limitation of the data and variables that would be
present if you had an opportunity to design the study from the begin-
ning and oversee data collection. If we had control of the data set, we
certainly would be interested in examining ventricular function. In
addition, there is selection bias associated with retrospective admin-
istrative databases and an inability to recognize undocumented
inherent patient differences.
Rather than focusing on the weaknesses of these studies, I like to
focus on the strengths, being that these types of studies provide
a broad multi-institutional sample. They allow examination of out-
comes that are applicable to both small centers and large academic
institutions. They offer another tool for providing evidence-based
guidelines for our patients. I think the best way to address variables
that are not present in the data set is to conduct a secondary study,
perhaps using institutional data where you can control what vari-
ables are present. In fact, we are in the process of conducting a sim-
ilar study based on our own institutional data with patients
undergoing CABG, and we hope that this will provide some of
the answers that are not readily available using the California data-
base.
Dr Mitruka. The anatomic location and size of the infarct are
allegedly addressed by the comorbidity index, the Charlson index.
However, it is also well recognized that patients with transmural in-
farcts that are perhaps anterior infarcts pose a higher risk in the peri-
operative period when operated on sooner rather than later. Was
there any way to distinguish those patients in this database during
your analysis to come up with a subgroup of patients who perhaps
were at even higher risk?
Dr Weiss. We could identify the location of the infarct on the
basis of the data we had. We incorporated that information into
our propensity adjustment. On the multivariable logistic
regression, we only used anterolateral infarct because that was the
only factor that was a significant predictor of mortality on univariate
analysis. So the answer to your question is yes, we did look at those
variables. We incorporated them in a univariate model, and then we
used them in our multivariable model accordingly.
DrMitruka.We, as clinical surgeons, oftentimes feel as though
the longer we can wait, or we are taught to believe that the longer we
can wait after an AMI before operating, the better, so I was a bit sur-
prised to see that the longer you waited with patients, 2 to 3 weeks
after an MI, the higher the mortality. We would have expected that
the mortality decreases over the course of time. Would you com-
ment on that?
Dr Weiss. As you pointed out, according to the studies done by
the Columbia group, you would expect mortality to decrease over
time. That has been shown in the past, and our findings would
seem to contradict their findings. I think the difference lies in the
fact that we looked at a subset of patients who were hospitalized
and could not be discharged. Previous studies looked at patients
who could be discharged. We thus examined a more acute cohort
of patients, and I speculate that the reason some of these patients
had higher mortality was because those who underwent operation510 The Journal of Thoracic and Cardiovascular Surgery c Malater possessed higher clinical acuity with more comorbidities.
This is perhaps the type of patient who has brittle diabetes, conges-
tive heart failure, or COPD. This is the type of patient who you
would prefer not to operate on, but for one reason or another later
on in their hospitalization your hand is forced. We do have data to
back that up. We examined that subset of patients, the late patients,
and we did see that their Charlson Index was a full point higher than
that of the remainder of the study population, so they indeed had
a higher comorbidity index. In addition, those patients had a higher
percentage of shock, higher percentage of intraaortic balloon pump,
so I suspect that the difference is that our patient population is
slightly different and that those patients operated on later were
more acutely ill.
Member of the audience: I just want to ask one quick question.
Did you look at the mortality rate for AMI without surgery? Is this
an effect that occurs because the highest death rate from AMI is
early, and this is an effect maybe of the disease rather than surgery?
Dr Weiss. That is a good point. We did not specifically do the
same analysis on AMI without surgery. We designed the study to
capture data such that we only looked at those who received surgery.
I agree with you, and I think it is probably true that this is a function
of the disease process, but within that disease process, if we look at
the subset of those who have required surgery, we should still be
able to identify the optimal time for CABG surgery in that cohort.
Dr Vallieres (Seattle, Wash). I am not a cardiac surgeon but I
was wondering if you had looked at which day of the week (eg,
Monday, Tuesday) when the infarct occurred and correlated to the
day of the week when the revascularization occurred and whether
this had an impact on these variables.
Dr Weiss.We did not. It was not present in the data set, and we
did not look at it.
Dr Cohen. I had a couple of questions, but as the discussion en-
sued they turned into comments. The first comment is that I have to
take issue with the statement that there are patients early on who
would have fared better had you waited to operate. I think the study
of your design might have been better had you excluded some of the
patients who were absolutely without question going to die early
without operation because I think they would have died had you
waited, and so I think that invalidates that statement.
The second thing is that I have to emphasize what our primary
discussant said. I think that ventricular function in the face of
AMI and in determining when that patient is going to undergo op-
eration is absolutely crucial, and I think that might be the fatal
blow in determining the validity of this study because this study is
incredibly important. Heart surgeons are going to rely on studies
such as this in determining how to make life and death decisions
for patients. I just don’t know how you can do it without knowing
what the ventricular function is in the face of an AMI.
DrWeiss.As I said, we are attempting to perform a second study
using our own institutional data that may answer some of those
questions.
Dr Slater (Portland, Ore). I have some quick data questions.
Did you segregate the data for men and women? Is the day of hos-
pitalization the same as the day of MI for your group or was there
any variability in that some patients come in several days after their
MI? You have the date of surgery, but did you break it down by pa-
tients who came in, had an AMI on sayMonday, Tuesday, are cathe-
terized, and you are operating Tuesday night, versus patients whorch 2008
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they are done as an elective case?
Dr Weiss. We did not segregate on the basis of gender. We did
look at gender in our multivariable model. Female gender was a pre-
dictor of worse outcomes, as has been shown previously.
The structure of the database does not really allow us to discrim-
inate based on the hours at which you receive your CABG. It is only
based on days. It is one of the limitations of the study, and we
acknowledge that.The Journal of ThoTo answer your question about which patients presented and
when they presented, these were all patients whose hospital day
zero was their initial day of hospitalization, and it was also their
day of presentation, the day that they had an AMI. We went to
great efforts to identify patients who were admitted to the hospital
solely with the principle diagnosis of AMI. For example, we
excluded hospital transfers. We wanted to identify a group of
patients for whom day zero truly was the day that they were
admitted with AMI.racic and Cardiovascular Surgery c Volume 135, Number 3 511
